Amniotic Products market growth at a CAGR of ~ 9.1% from 2021 to 2027


Latest Study on “Amniotic Products Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2027”.

The global Amniotic Products market size is expected to be worth around US$ 2.0 Billion by 2027, according to a new report by nova one advisor.

The global Amniotic Products market size was valued at US$ 1.5 Billion in 2020 and is anticipated to grow at a CAGR of 9.1% during forecast period 2021 to 2027.

Get your Customized Research Report@

Growth Factors:

The growth in this market can be attributed to the growth in the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management, rising venture capital investments and government funding, increasing number of traumatic wounds, growing number of amniotic membrane transplantations, and the increasing number of ophthalmology, cosmetic, and orthopedic surgeries. Emerging economies, implementation of the 21st-century cures act, and increasing demand for stem cell research and regenerative medicine are expected to offer strong growth opportunities for players in the market. In contrast, the complications and limitation associated with the use of amniotv membrane may challenge market growth to a certain extent. The amniotic products market is segmented based on type, application, end user, and region.

Global Amniotic products Market Dynamics
DRIVER: Rising incidence of burn injuries
The high incidence of burn wounds has resulted in a significant increase in the demand for wound care biologics, including amniotic membranes. According to the WHO, a majority of burn cases occur in low- and middle-income countries, and almost two-thirds occur in the WHO African and Southeast Asian regions. For instance, in India, 1 million people suffer from moderate and severe burns every year (Source: WHO). The incidence of burns is also high in other Southeast Asian countries such as Bangladesh and Nepal. An estimated 173,000 children suffer from moderate or severe burns in Bangladesh every year. In Nepal, burns are the second-most common injury, accounting for 5% of all disabilities.

OPPORTUNITY: Implementation of the 21st Century Cures Act (US)
The 21st Century Cures Act was signed into law in the US in December 2016. Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation. The Act covers various provisions that may impact the development and approval of several products in the coming years. Under this Act, a new “Regenerative Medicine Advanced Therapy” designation has been established, along with a fast-track approval pathway for new regenerative medicine products and therapies. The implementation of this Act can potentially result in the approval of new regenerative medicine products and therapies in the US, as well as stimulate R&D activities in the field of regenerative medicine.

CHALLENGE: Complications and limitations associated with the use of amniotic membranes
Amniotic membranes are not to be used indiscriminately since there could be an occasional risk of complications. The patient or the recipient of an amniotic membrane could transmit bacterial, viral, or fungal infections if the donors are not adequately screened for communicable diseases. Other risks to the patient/recipient may also occur if the membrane is not processed under sterile conditions, or if the membrane is inappropriately stored. Incidence rates of 1.6% to 8.0% have been reported post amniotic membrane transplantation, with gram-positive isolates being reported most frequently. Also, premature degradation of an amniotic membrane and cheese wiring may further lead to frequent and repetitive transplantations, which in itself is a risk.

Amniotic membrane segment dominated the Amniotic products market in 2020.
Based on type, the amniotic products market is segmented into amniotic membranes and amniotic suspensions. Amniotic membrane account for the largest share of the amniotic products market. The large share of this segment can be attributed to its increased use in a number of procedures. Moreover, amniotic membranes are more effective than amniotic suspensions.

The wound care segment to witness the highest CAGR during the forecast period.
Based on application, the amniotic products market is segmented into wound care, ophthalmology, orthopedics, and other applications. The wound care applications segment commanded the largest share of the amniotic products market. . The large share of this segment can be attributed to the growing incidence of ulcers, traumatic and surgical wounds, and burns and the need for advanced technologies for treatment.

North America was the largest regional market for amniotic products market in 2020.
The global amniotic products market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, and the Rest of Asia Pacific), Latin America and Middle East & Africa. In 2020, North America dominated the global amniotic products market, followed by Europe. The large share of the North American market can be attributed to the high prevalence of target diseases, increasing geriatric population, rising awareness about advanced treatment options, and the strong presence of key market players in the region.

Buy Complete Assessment of Amniotic Products market Now@

COVID-19 Impact on Amniotic Products Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Amniotic Products market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Amniotic Products market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Amniotic Products market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Amniotic Products market include: 

MiMedx, Smith & Nephew, Organogenesis Inc., Integra LifeSciences, Stryker, Applied Biologics, Celularity, Inc., Katena Products, Inc., Lucina BioSciences, Next Biosciences, Skye Biologics Holdings, LLC, Surgenex, TissueTech, Inc., Ventris Medical, LLC, StimLabs LLC, VIVEX Biologics, Inc., LifeCell International Pvt. Ltd., NuVision Biotherapies Ltd., Genesis Biologics, Surgilogix, Tides Medical, Orthofix Medical Inc., AlloSource, Merakris Therapeutics, and MTF Biologics.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

By Type

  • Amniotic Membranes
    • Cryopreserved Amniotic Membranes
    • Dehydrated Amniotic Membranes
  • Amniotic Suspensions

By Application

  • Wound Care
  • Orthopedics
  • Ophthalmology
  • Other Applications

By End User

  • Hospitals & ASCs
  • Other End Users

Browse Complete Table of Content@

Why Buy this Report?

The purpose of Nova one advisor’s Amniotic Products market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Download This Full Research Report, Click Here@

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333



James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →

Leave a Reply

Your email address will not be published. Required fields are marked *